Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.
The rise in plasma neopterin observed with increasing severity of vascular disease is a strong indicator of the inflammatory nature of atherosclerosis. Plasma neopterin originates as the oxidation product of 7,8-dihydroneopterin secreted by gamma-interferon stimulated macrophages within atherosclerotic plaques. Neopterin is increasingly being used as a marker of inflammation during clinical management of patients with a range of disorders including atherosclerosis. Yet the role of 7,8-dihydroneopterin/neopterin synthesis during the inflammatory process and plaque formation remains poorly understood and controversial. This is partially due to the unresolved role oxidants play in atherosclerosis and the opposing roles of 7,8-dihydroneopterin/neopterin. Neopterin can act as pro-oxidant, enhancing oxidant damage and triggering apoptosis in a number of different cell types. Neopterin appears to have some cellular signalling properties as well as being able to chelate and enhance the reactivity of transition metal ions during Fenton reactions. In contrast, 7,8-dihydroneopterin is also a radical scavenger, reacting with and neutralizing a range of reactive oxygen species including hypochlorite, nitric oxide and peroxyl radicals, thus protecting lipoproteins and various cell types including macrophages. This has led to the suggestion that 7,8-dihydroneopterin is synthesized to protect macrophages from the oxidants released during inflammation. The oxidant/antioxidant activity observed in vitro appears to be determined both by the relative concentration of these compounds and the specific chemistry of the in vitro system under study. How these activities might influence or modulate the development of atherosclerotic plaque in vivo will be explored in this review.
Gieseg
S P
SP
School of Biological Sciences, University of Canterbury, Christchurch, New Zealand. Steven.Gieseg@canterbury.ac.nz
Crone
E M
EM
Flavall
E A
EA
Amit
Z
Z
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D050197:Atherosclerosis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015415:Biomarkers / Q000097:blood; D002118:Calcium / Q000378:metabolism; D016166:Free Radical Scavengers / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008077:Lipoproteins, LDL / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D019798:Neopterin / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D016877:Oxidants / Q000378:metabolism*; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000187:drug effects; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D016166:Free Radical Scavengers; D008077:Lipoproteins, LDL; D016877:Oxidants; D017382:Reactive Oxygen Species; C099252:oxidized low density lipoprotein; C000976:7,8-dihydroneopterin; D019798:Neopterin; D002118:Calcium
Cancer Res. 1991 Dec 1;51(23 Pt 1):6250-3
1933885
J Immunol. 1987 Nov 15;139(10):3474-83
2824608
Eur Heart J. 1993 Dec;14 Suppl K:94-7
8131797
Arterioscler Thromb Vasc Biol. 2004 May;24(5):949-54
15001454
Biochim Biophys Acta. 2002 Aug 19;1591(1-3):139-145
12183064
Clin Chem Lab Med. 2000 Apr;38(4):345-53
10928656
J Leukoc Biol. 2002 Dec;72(6):1148-53
12488496
Clin Exp Immunol. 2003 Feb;131(2):264-7
12562386
Biochem Biophys Res Commun. 1997 May 29;234(3):774-8
9175792
Oncogene. 1996 Nov 21;13(10):2281-5
8950996
Free Radic Res. 2003 Sep;37(9):983-91
14670006
Heart. 2000 Mar;83(3):346-50
10677418
FEBS Lett. 1993 Mar 8;318(3):249-52
8440379
Eur J Cell Biol. 2002 Apr;81(4):197-202
12018387
Atherosclerosis. 2006 Aug;187(2):238-50
16412446
J Biol Chem. 1994 May 20;269(20):14457-64
7514170
J Lipid Res. 1997 May;38(5):992-1001
9186916
Free Radic Biol Med. 2005 Jun 15;38(12):1571-84
15917186
Atherosclerosis. 1992 May;94(1):87-8
1632862
Immunobiology. 1998 Jul;199(1):63-73
9717668
Arch Biochem Biophys. 1994 Apr;310(1):60-3
8161222
Lung. 1984;162(6):337-46
6527565
J Leukoc Biol. 1996 Apr;59(4):555-61
8613704
Neurochem Int. 2002 Jul;41(1):71-8
11918974
Biochim Biophys Acta. 2005 Sep 30;1745(3):361-9
16084608
Biochem Biophys Res Commun. 2000 Aug 28;275(2):307-11
10964663
Redox Rep. 2000;5(2-3):98-100
10939282
J Am Coll Cardiol. 1997 Sep;30(3):703-7
9283529
Immunobiology. 2000 Jan;201(3-4):478-91
10776802
Biochem J. 1992 Dec 1;288 ( Pt 2):341-4
1463440
Biochim Biophys Acta. 2004 Apr 7;1672(1):46-50
15056492
Clin Chim Acta. 1991 Sep 14;201(1-2):1-16
1790613
J Am Coll Cardiol. 2000 Mar 15;35(4):956-62
10732894
Immunol Lett. 2000 May 1;72(2):133-6
10841949
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2506-10
2320571
Free Radic Res. 2004 Jan;38(1):9-17
15061649
Int J Tuberc Lung Dis. 2003 Aug;7(8):771-6
12921154
Clin Chem Lab Med. 2003 Oct;41(10):1314-9
14580158
FEBS Lett. 1996 Nov 18;397(2-3):263-8
8955360
Immunobiology. 2001 May;203(4):629-41
11402497
J Lipid Res. 1997 Sep;38(9):1730-45
9323583
J Biol Chem. 1999 Sep 10;274(37):25959-62
10473535
J Biol Chem. 1997 Feb 7;272(6):3520-6
9013599
Transplantation. 1983 Dec;36(6):650-3
6362141
Clin Chim Acta. 2003 Dec;338(1-2):157-64
14637281
Biochim Biophys Acta. 2005 Jun 20;1724(1-2):17-22
15890449
J Biochem Biophys Methods. 1988 May;16(1):27-40
3135299
Biochem J. 2000 Dec 15;352 Pt 3:693-9
11104675
Biochem Biophys Res Commun. 2004 Aug 20;321(2):379-85
15358187
Atherosclerosis. 1993 Feb;99(1):107-20
8384855
J Infect Dis. 2006 Nov 15;194(10):1438-46
17054074
Eur J Intern Med. 2000 Apr;11(2):89-95
10745152
Free Radic Res. 2002 May;36(5):509-20
12150539
Circulation. 2002 Mar 5;105(9):1135-43
11877368
Adv Clin Chem. 1989;27:81-141
2667296
Free Radic Res. 2007 Jul;41(7):839-48
17577745
Arterioscler Thromb Vasc Biol. 1999 Jul;19(7):1708-18
10397689
Free Radic Res. 2001 Feb;34(2):123-36
11264890
Eur J Biochem. 1987 Jul 15;166(2):303-10
3301338
J Biol Chem. 1989 Sep 15;264(26):15216-23
2768257
Biochim Biophys Acta. 1995 May 17;1256(2):141-50
7766691
J Pathol. 1996 Dec;180(4):423-9
9014864
Biochem Biophys Res Commun. 1998 Jul 20;248(2):341-6
9675137
J Clin Invest. 1994 Jul;94(1):437-44
8040285
Clin Chem. 1992 Sep;38(9):1722-4
1526005
Free Radic Res. 1995 Aug;23(2):123-36
7581810
FEBS Lett. 1995 May 8;364(2):234-8
7750578
Cardiovasc Res. 1999 Feb;41(2):334-44
10341833
J Mol Cell Cardiol. 2000 Jul;32(7):1265-74
10860768
Trans R Soc Trop Med Hyg. 1984;78(4):545-6
6485060
FEBS Lett. 2001 Jun 15;499(1-2):69-72
11418114
J Clin Invest. 1989 Oct;84(4):1086-95
2794046
Biochem Biophys Res Commun. 1999 Oct 14;264(1):262-7
10527875
Biochem J. 2003 Mar 1;370(Pt 2):729-35
12456264
Clin Chem. 1987 Nov;33(11):2028-33
3119253
Cancer Res. 1990 May 15;50(10):2863-7
2110500
Arteriosclerosis. 1989 Jul-Aug;9(4):538-49
2751482
Angiology. 1998 Dec;49(12):957-66
9855370
Free Radic Biol Med. 1994 Jan;16(1):131-3
7507878
Trends Biochem Sci. 1991 Oct;16(10):369-73
1785138
J Clin Invest. 1994 May;93(5):2149-58
8182147
Atherosclerosis. 1991 Aug;89(2-3):203-8
1793448
Arthritis Rheum. 1986 Sep;29(9):1063-70
3753537
Immunol Today. 1988 May;9(5):150-5
3076770
Nephrol Dial Transplant. 2002 Jun;17(6):1032-6
12032193
FEBS Lett. 1992 Jun 15;304(2-3):163-6
1319924
Free Radic Res. 2001 Sep;35(3):311-8
11697129
Redox Rep. 2003;8(2):113-5
12804014
Curr Opin Lipidol. 2001 Oct;12(5):535-41
11561173
Antioxid Redox Signal. 2001 Feb;3(1):157-63
11291594
FEBS Lett. 1995 Jan 23;358(2):175-8
7828731
Atherosclerosis. 1995 Nov;118(1):67-75
8579633
Mediators Inflamm. 2002 Jun;11(3):181-5
12137247
FEBS Lett. 1996 Aug 5;391(1-2):181-4
8706912
J Biol Chem. 1996 Dec 20;271(51):32714-21
8955104
Coron Artery Dis. 2006 Sep;17(6):511-6
16905962
Proc Natl Acad Sci U S A. 1979 Jan;76(1):333-7
218198
Redox Rep. 2003;8(2):81-6
12804010
Metabolism. 1996 Sep;45(9):1069-79
8781293
Biochem Pharmacol. 1998 Nov 1;56(9):1181-7
9802329
Scand J Immunol. 1994 Jan;39(1):27-30
8290891
J Clin Invest. 1990 Feb;85(2):554-62
2153710